Logo image of BAI.AS

Odyssey Acquisition SA (BAI.AS) Stock Price, Quote, News and Overview

AMS:BAI - Euronext Amsterdam - LU2355630455 - Common Stock - Currency: EUR

0.081  -0.01 (-14.74%)

BAI.AS Quote, Performance and Key Statistics

Odyssey Acquisition SA

AMS:BAI (3/12/2025, 7:00:00 PM)

0.081

-0.01 (-14.74%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High0.91
52 Week Low0.07
Market Cap11.58M
Shares143.02M
Float85.31M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO07-02 2021-07-02


BAI.AS short term performance overview.The bars show the price performance of BAI.AS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

BAI.AS long term performance overview.The bars show the price performance of BAI.AS in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of BAI.AS is 0.081 EUR. In the past month the price decreased by -57.37%. In the past year, price decreased by -88.75%.

Odyssey Acquisition SA / BAI Daily stock chart

BAI.AS Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY.DE ELI LILLY & CO 40.18 530.12B
1LLY.MI ELI LILLY & CO 39.07 515.48B
ZEG.DE ASTRAZENECA PLC 16.85 397.48B
JNJ.DE JOHNSON & JOHNSON 17.19 356.82B
RHO.DE ROCHE HOLDING AG-BR 13.13 221.90B
SAN.PA SANOFI 11.02 202.87B
SNW.DE SANOFI 10.81 199.09B
1SAN.MI SANOFI 10.74 197.73B
NOT.DE NOVARTIS AG-REG 13.52 197.11B
NOV.DE NOVO NORDISK A/S-B 12.86 193.20B
6MK.DE MERCK & CO. INC. 10.53 175.27B
1MRKX.MI MERCK & CO. INC. 10.35 172.26B

About BAI.AS

Company Profile

BAI logo image BenevolentAI SA is a holding company that engages in the research and development and sale of AI-enabled drugs. The firm designs its technology to enable scientists to better understand the development of disease mechanisms, discover drug targets and make decisions. The company serves patients by leveraging its proprietary and validated Benevolent Platform that integrates AI and science to uncover new biology, predict novel targets and develop drugs for complex diseases. The Benevolent Platform integrates technology, processes, and humans for faster research and development success. Its pipeline includes BEN-8744, BEN-28010, BEN-34712, Parkinson's disease, and Fibrosis. BEN-8744 is developed for the treatment of an ulcerative colitis. The firm provides scientists with a view of disease biology by integrating across all the domains and diverse data types, including omics, molecules, experimental data, literature, pathology, and biological systems.

Company Info

Odyssey Acquisition SA

4-8 Maple Street

London GB

Employees: 180

BAI Company Website

BAI Investor Relations

Phone: 442037819360

Odyssey Acquisition SA / BAI.AS FAQ

What is the stock price of Odyssey Acquisition SA today?

The current stock price of BAI.AS is 0.081 EUR. The price decreased by -14.74% in the last trading session.


What is the ticker symbol for Odyssey Acquisition SA stock?

The exchange symbol of Odyssey Acquisition SA is BAI and it is listed on the Euronext Amsterdam exchange.


On which exchange is BAI.AS stock listed?

BAI.AS stock is listed on the Euronext Amsterdam exchange.


What is the price forecast or stock price prediction for Odyssey Acquisition SA stock?

5 analysts have analysed BAI.AS and the average price target is 2.75 EUR. This implies a price increase of 3300% is expected in the next year compared to the current price of 0.081. Check the Odyssey Acquisition SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is Odyssey Acquisition SA worth?

Odyssey Acquisition SA (BAI.AS) has a market capitalization of 11.58M EUR. This makes BAI.AS a Nano Cap stock.


How many employees does Odyssey Acquisition SA have?

Odyssey Acquisition SA (BAI.AS) currently has 180 employees.


Is Odyssey Acquisition SA (BAI.AS) expected to grow?

The Revenue of Odyssey Acquisition SA (BAI.AS) is expected to decline by -31.89% in the next year. Check the estimates tab for more information on the BAI.AS EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy Odyssey Acquisition SA (BAI.AS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does Odyssey Acquisition SA (BAI.AS) stock pay dividends?

BAI.AS does not pay a dividend.


What is the Price/Earnings (PE) ratio of Odyssey Acquisition SA (BAI.AS)?

Odyssey Acquisition SA (BAI.AS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.51).


BAI.AS Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

BAI.AS Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to BAI.AS. BAI.AS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BAI.AS Financial Highlights

Over the last trailing twelve months BAI.AS reported a non-GAAP Earnings per Share(EPS) of -0.51. The EPS increased by 33.78% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -54.61%
ROE -73.07%
Debt/Equity 0.05
Chartmill High Growth Momentum
EPS Q2Q%34.91%
Sales Q2Q%-46.5%
EPS 1Y (TTM)33.78%
Revenue 1Y (TTM)-55.8%

BAI.AS Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to BAI.AS. The Buy consensus is the average rating of analysts ratings from 5 analysts.

For the next year, analysts expect an EPS growth of 8.46% and a revenue growth -31.89% for BAI.AS


Ownership
Inst Owners22.95%
Ins Owners23.71%
Short Float %N/A
Short RatioN/A
Analysts
Analysts80
Price Target2.75 (3295.06%)
EPS Next Y8.46%
Revenue Next Year-31.89%